Back to Journals » Lung Cancer: Targets and Therapy » Volume 9

Lung Cancer: Targets and Therapy


Archive: Volume 9, 2018

Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation

Zhu VW, Schrock AB, Bosemani T, Benn BS, Ali SM, Ou SI

Lung Cancer: Targets and Therapy 2018, 9:111-116

Published Date: 8 November 2018

Silicosis and lung cancer: current perspectives

Sato T, Shimosato T, Klinman DM

Lung Cancer: Targets and Therapy 2018, 9:91-101

Published Date: 26 October 2018

Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation

Abdallah N, Nagasaka M, Abdulfatah E, Shi D, Wozniak AJ, Sukari A

Lung Cancer: Targets and Therapy 2018, 9:85-90

Published Date: 25 October 2018

Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update

Pollock AE, Shinn L, Anderson R, Butler S, Pollock J

Lung Cancer: Targets and Therapy 2018, 9:79-84

Published Date: 10 September 2018

1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT

Albano D, Bilfinger T, Nemesure B

Lung Cancer: Targets and Therapy 2018, 9:65-71

Published Date: 24 August 2018

Comprehensive review of fetal adenocarcinoma of the lung

Ricaurte LM, Arrieta O, Zatarain-Barrón ZL, Cardona AF

Lung Cancer: Targets and Therapy 2018, 9:57-63

Published Date: 23 August 2018

Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes

Manapov F, Käsmann L, Roengvoraphoj O, Dantes M, Schmidt-Hegemann NS, Belka C, Eze C

Lung Cancer: Targets and Therapy 2018, 9:49-55

Published Date: 16 August 2018

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

Parikh AR, Ali SM, Schrock AB, Albacker LA, Miller VA, Stephens PJ, Crilley P, Markman M

Lung Cancer: Targets and Therapy 2018, 9:45-47

Published Date: 18 May 2018

Role and inhibition of GLI1 protein in cancer

Mastrangelo E, Milani M

Lung Cancer: Targets and Therapy 2018, 9:35-43

Published Date: 27 March 2018

Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients

Syahruddin E, Wulandari L, Sri Muktiati N, Rima A, Soeroso N, Ermayanti S, Levi M, Hidajat H, Widjajahakim G, Utomo ARH

Lung Cancer: Targets and Therapy 2018, 9:25-34

Published Date: 23 March 2018

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K

Lung Cancer: Targets and Therapy 2018, 9:1-11

Published Date: 3 January 2018